Thyroid disease in perimenopausal and postmenopausal women

Infertility and Reproductive Medicine Clinics of North America

Volumn 12, Issue 3, 2001, Pages 585-603

  Pearce, E N ^a   Braverman, L E ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COLESTYRAMINE; DROLOXIFENE; ESTROGEN; FERROUS SULFATE; LEVOTHYROXINE; LEVOTHYROXINE SODIUM; PROPYLTHIOURACIL; RADIOACTIVE IODINE; RALOXIFENE; RIFAMPICIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SUCRALFATE; TAMOXIFEN; THIAMAZOLE;

AGING; AGRANULOCYTOSIS; CLINICAL FEATURE; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; FEMALE; GRAVES DISEASE; HEART DISEASE; HORMONAL THERAPY; HUMAN; HYPERCHOLESTEROLEMIA; HYPOTHYROIDISM; MENOPAUSE; NEUROLOGIC DISEASE; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PREMENOPAUSE; RASH; REVIEW; SCREENING; THYROID CANCER; THYROID DISEASE; THYROID FUNCTION; THYROID NODULE; THYROTOXICOSIS; URTICARIA;

EID: 0034944938     PISSN: 10479422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (121)

1. Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: A mechanism for estrogen-induced elevation of serum TBG concentration
2. Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism
3. Thyroid function in postmenopausal breast cancer patients treated with tamoxifen
4. Estrogen replacement therapy (ERT) increases thyroxine requirements in treated-hypothyroid women
5. Minimally symptomatic (subclinical) hypothyroidism
6. Thyroid dysfunction in adults over age 55 years: A study in an urban US community
7. Asymptomatic hypothyroidism and hypercholesterolemia
8. Editorial: Thyroid hormones and bone mass
9. End-organ responses to thyroxine therapy in subclinical hypothyroidism
10. Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter
11. Total and age-specific incidence of Graves' thyrotoxicosis, toxic nodular goitre and solitary toxic adenoma in Malmo 1970-1974
12. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism
13. A study of thyroid function in the premenopause and postmenopause
14. Introduction to hypothyroidism
15. Introduction to thyrotoxicosis
16. Treatment of hypothyroidism
17. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism
18. Discontinuing antithyroid drug therapy before ablation with radioiodine in Graves' disease
19. Ionized and total serum calcium and parathyroid hormone in hyperthyroidism
20. The Colorado thyroid disease prevalence study
21. 3 index
22. Fine adjustment of thyroxine replacement dosage: Comparison of the thyrotropin releasing hormone test using a sensitive thyrotropin assay with measurement of free thyroid hormones and clinical assessment
23. Hypothalamic-pituitary-thyroid axis status of humans during development of aging process
24. L-thyroxine therapy in subclinical hypothyroidism
25. Treatment of thyrotoxicosis
26. Mild hyperthyroidism with inappropriate secretion of TSH in postmenopausal women
27. Screening for mild thyroid failure at the periodic health examination: A decision and cost-effectiveness analysis
28. Hyperthyroidism in patients over the age of 60 years: Clinical features in 85 patients
29. A clinico-pathological survey of thyroid glands in old age
30. Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia
31. Does age play a role in clinical presentation of hypothyroidism?
32. Normalization of serum thyrotropin by means of radioiodine treatment in subclinical hyperthyroidism: Effect on bone loss in postmenopausal women
33. Subclinical hypothyroidism
34. Relationship of age to the thyroidal accumulation, renal excretion and distribution of radioiodide in euthyroid man
35. Differentiated thyroid carcinoma (DTC) in the elderly: Disease outcome, therapeutic approach, and long-term results in a group of 314 patients
36. The effect of tamoxifen therapy on thyroid function tests
37. Subclinical hypothyroidism: A modifiable risk factor for depression?
38. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam study
39. The structure of the human thyroid in relation to aging and focal thyroiditis
40. Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridium cross-links as specific urinary markers
41. The thyroid and aging
42. Conjugated estrogen therapy and tests of thyroid function
43. The interface between thyroid hormones and psychiatry
44. Serum thyrotropin and thyroid hormone levels in elderly and middle-aged euthyroid persons
45. 4, and thyroid antibodies in the United States population: NHANES III
46. The thyroid gland and reproduction
47. Does thyroid hormone have a role as adjunctive therapy in depression?
48. Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism?
49. Subclinical thyroid dysfunction in the elderly
50. Subclinical hypothyroidism: Natural course of the syndrome during a prolonged follow-up study
51. Cardiac risks of hyperthyroidism in the elderly
52. Atherosclerosis and the thyroid
53. Subclinical hyperthyroidism
54. Menstrual disturbances in thyrotoxicosis
55. Thyrotoxicosis and the heart: Something old and something new
56. American Thyroid Association guidelines for detection of thyroid dysfunction
57. Nonactivated (apathetic) type of hyperthyroidism
58. Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism
59. Morbidity in patients on L-thyroxine: A comparison of those with a normal TSH to those with a suppressed TSH
60. A study of age-dependent changes in thyroid function tests in adults
61. Thyroid function test changes with adjuvant tamioxifen therapy in postmenopausal women with breast cancer
62. Thyroid-directed antibodies
63. Thyroid and other organ-specific autoantibodies in healthy centenarians
64. Complex alterations of thyroid function in healthy centenarians
65. The aging thyroid
66. Thyroid autoimmunity and aging
67. Hyperthyroidism in the elderly: Differences in the clinical findings compared with younger patients
68. The effects of droloxifene and estrogen on thyroid function in postmenopausal women
69. Specific problems in the management of thyroid cancer
70. The advisability of screening for thyroid disease in perimenopausal and postmenopausal women prior to HRT
71. In vivo radionuclide tests and imaging
72. Thyroid disease in the elderly
73. Subclinical hypothyroidism: Neurobehavioral features and beneficial effects of L-thyroxine treatment
74. Age-related modifications in the regulation of the hypothalamic-pituitary-thyroid axis
75. Bone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism
76. Thyroid and ageing
77. Management of atrial fibrillation in the post-thyrotoxic state
78. Clinical significance of psychoneuroendocrinology in psychiatry: Focus on the thyroid and adrenal
79. Age-related changes of serum 3, 3′-diiodothyronine, 3′, 5′-diiodothyronine, and 3,5-diiodothyronine concentrations in man
80. Graves' disease: Influence of age on classic findings
81. A double-blind cross-over 12-month study of L-thyroxine treatment of women with subclinical hypothyroidism
82. Hyperlipidemia in patients with primary and secondary hypothyroidism
83. Autoantibodies and immunoglobulin haplotypes in healthy North American blacks of different age groups
84. Low serum triiodothyronine and high serum reverse triiodothyronine in old age: An effect of disease not age
85. Hormones in young and old elderly: Pituitary-thyroid and pituitary-adrenal axes
86. Thyroid autoimmunity and aging
87. Size and structure of the thyroid in old age
88. Peripheral responses to thyroid hormone before and after L-thyroxine therapy in patients with subclinical hypothyroidism
89. Cardiac function in mild and severe primary hypothyroidism
90. Recognizing the cardiovascular effects of hypothyroidism
91. Clinical evaluation of solitary thyroid nodules
92. Involutional osteoporosis
93. Hypothyroidism in the elderly
94. Effect of L-thyroxine administration on antithyroid antibody levels, lipid profile, and thyroid volume in patients with Hashimoto's thyroiditis
95. Thyroid failure in the elderly: Microsomal antibodies as discriminant for therapy
96. Subclinical hyperthyroidism: Possible danger of overzealous thyroxine replacement therapy
97. Subclinical hypothyroidism
98. Subclinical thyrotoxicosis
99. Progressive decrease in serum triiodothyronine concentrations with human aging: Radioimmunoassay following extraction of serum
100. Thyroid function in a healthy elderly population: Implications for clinical evaluation
101. The aging thyroid: Increased prevalence of elevated serum thyrotropin levels in the elderly
102. The aging thyroid: Thyroid deficiency in the Framingham Study
103. The aging thyroid: Relationship between elevated serum thyrotropin level and thyroid antibodies in elderly patients
104. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons
105. Age-related changes in thyroid function
106. The aging thyroid in health and disease
107. Thyroid dysfunction and hypercholesterolemia in the general population of Glasgow, Scotland
108. Treatment guidelines for patients with hyperthyroidism and hypothyroidism
109. Thyroid function and dysfunction in the elderly: A brief review
110. Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine
111. Diagnostic algorithm for atrial fibrillation caused by occult hypothyroidism
112. Subclinical thyroid disease
113. Serum thyroglobulin in hospitalized chronic geriatric patients: Its relationship to age, nonthyroidal illness, goitre and thyroid dysfunction in a follow-up study
114. Thyroid autoantibodies in hospitalized chronic geriatric patients: Prevalence, effects of age, nonthyroidal clinical state, and thyroid function
115. Hypothyroidism: Diversity of presentation
116. Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: A reanalysis of intervention studies
117. Differences in the signs and symptoms of hyperthyroidism in older and younger patients
118. The spectrum of thyroid disease in a community: The Whickham survey
119. Decreased basal and stimulated thyrotropin secretion in healthy elderly men
120. The epidemiology of thyroid diseases